Patients With Breast Cancer and BRCA1, BRCA2, CHEK2, or PALB2 Germline Pathogenic Variants May Benefit From Enhanced Surveillance
Oncology Nursing News,
Women with a breast cancer with known germline pathogenic variants (PV) in BRCA1, BRCA2, CHEK2, or PALB2 may benefit from…